Alcon Inc (ALC)
89.06
-0.91
(-1.01%)
USD |
NYSE |
May 16, 16:00
89.05
-0.01
(-0.01%)
Pre-Market: 20:00
Alcon Price: 89.06 for May 16, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 16, 2024 | 89.74 | 89.87 | 88.87 | 89.06 | 595113.0 |
May 15, 2024 | 89.90 | 90.00 | 89.05 | 89.97 | 1.456M |
May 14, 2024 | 88.66 | 89.32 | 87.30 | 89.28 | 1.956M |
May 13, 2024 | 82.13 | 82.73 | 80.86 | 80.92 | 1.527M |
May 10, 2024 | 81.13 | 82.08 | 80.97 | 82.01 | 1.194M |
May 09, 2024 | 80.63 | 81.72 | 80.63 | 81.46 | 671487.0 |
May 08, 2024 | 80.56 | 80.78 | 79.63 | 80.35 | 667752.0 |
May 07, 2024 | 79.90 | 81.18 | 79.90 | 80.97 | 946703.0 |
May 06, 2024 | 80.14 | 80.51 | 79.80 | 80.41 | 611190.0 |
May 03, 2024 | 79.58 | 80.08 | 79.36 | 79.57 | 594700.0 |
May 02, 2024 | 78.37 | 78.75 | 77.76 | 78.42 | 432281.0 |
May 01, 2024 | 77.61 | 79.65 | 77.58 | 78.53 | 525921.0 |
Apr 30, 2024 | 77.81 | 78.02 | 77.54 | 77.58 | 541823.0 |
Apr 29, 2024 | 79.21 | 79.52 | 78.59 | 78.72 | 686489.0 |
Apr 26, 2024 | 78.32 | 79.00 | 78.30 | 78.77 | 1.116M |
Apr 25, 2024 | 78.36 | 79.00 | 78.00 | 78.84 | 915924.0 |
Apr 24, 2024 | 80.28 | 80.28 | 79.50 | 79.57 | 853714.0 |
Apr 23, 2024 | 81.20 | 81.43 | 80.74 | 80.76 | 940672.0 |
Apr 22, 2024 | 80.53 | 81.00 | 79.92 | 80.61 | 521596.0 |
Apr 19, 2024 | 79.42 | 79.76 | 79.02 | 79.55 | 1.067M |
Apr 18, 2024 | 79.09 | 79.26 | 78.28 | 78.47 | 757057.0 |
Apr 17, 2024 | 79.93 | 79.95 | 78.82 | 79.00 | 1.164M |
Apr 16, 2024 | 80.40 | 80.40 | 79.24 | 79.61 | 1.073M |
Apr 15, 2024 | 82.17 | 82.47 | 80.98 | 81.09 | 701868.0 |
Apr 12, 2024 | 82.00 | 82.16 | 80.65 | 81.28 | 966651.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
39.86
Minimum
Mar 23 2020
89.97
Maximum
May 15 2024
69.58
Average
70.21
Median
Jun 04 2021
Price Benchmarks
Novartis AG | 102.69 |
AC Immune SA | 3.41 |
CRISPR Therapeutics AG | 55.67 |
Addex Therapeutics Ltd | 8.79 |
NLS Pharmaceutics Ltd | 0.1494 |
Price Related Metrics
PE Ratio | 42.21 |
PS Ratio | 4.624 |
PEG Ratio | 0.2007 |
Price to Book Value | 2.109 |
Price to Free Cash Flow | 106.28 |
Earnings Yield | 2.37% |
Market Cap | 43.93B |
PEGY Ratio | 0.2004 |
Operating PE Ratio | 38.82 |
Normalized PE Ratio | 42.21 |